Ezra Cohen, MD of the University of California at San Diego discusses if biomarkers help select patients more or less likely to benefit from agents targeting EGFR in SCCHN at ASTRO Head and Neck Symposium 2016.
Ezra Cohen, MD of the University of California at San Diego discusses if biomarkers help select patients more or less likely to benefit from agents targeting EGFR in SCCHN at ASTRO Head and Neck Symposium 2016.